Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631345 · ClinicalTrials.gov registry record · NA
Healthy Living Partnership to Prevent Diabetes
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT00631345: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT00631345 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 301 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00631345, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
The Healthy Living Partnership to Prevent Diabetes (HELP PD) is a 300-participant randomized trial designed to test the effectiveness of a lay-health counselor led community-based diabetes prevention program in reducing blood glucose in people at risk for developing diabetes mellitus.
Primary Outcome
Change in fasting glucose will be analyzed independently at 12 months (incorporating baseline and 6 month data) and will be used to report the average effect of the intervention during the first year. The analysis at 24 months (incorporating data from baseline, 18 and 24 months) will evaluate the long-term effects of the intervention by examining the average intervention effect during the second year of the intervention period.
Interventions
- BEHAVIORAL Group-Based Lifestyle Intervention (Phases 1 and 2)
- OTHER Individual Education Program (All Phases)
- BEHAVIORAL Self-Directed Maintenance (Phase 3)
- BEHAVIORAL Extended Group Maintenance (Phase 3)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2007-08 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT00631345 record still lists
NCT00631345 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 4 interventions - of which Group-Based Lifestyle Intervention (Phases 1 and 2) is the first listed.
NCT00631345 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00631345 about?
NCT00631345 is a clinical study titled "Healthy Living Partnership to Prevent Diabetes". The Healthy Living Partnership to Prevent Diabetes (HELP PD) is a 300-participant randomized trial designed to test the effectiveness of a lay-health counselor led community-based diabetes prevention program in reducing blood glucose in people at risk for developing diabetes mellitus.
What is the current status of trial NCT00631345?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2007-08. Estimated completion is 2015-05.
What interventions are being tested in trial NCT00631345?
The interventions under investigation include: Group-Based Lifestyle Intervention (Phases 1 and 2) (BEHAVIORAL), Individual Education Program (All Phases) (OTHER), Self-Directed Maintenance (Phase 3) (BEHAVIORAL), Extended Group Maintenance (Phase 3) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00631345?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00631345's enrollment target sits among peer trials
301 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia